ARTICLE | Clinical News
AR-42 regulatory update
June 18, 2012 7:00 AM UTC
The European Commission granted Orphan Drug designation for Arno's AR-42 to treat meningioma and schwannoma. The compound is in Phase I/IIa testing to treat multiple myeloma (MM), chronic lymphocytic ...